The multifaceted contributions of leukocyte subsets to atherosclerosis: lessons from mouse models (original) (raw)

• Hansson, G. K. Inflammation, atherosclerosis, and coronary artery disease. N. Engl. J. Med. 352, 1685–1695 (2005).
  CAS PubMed Google Scholar
• Zernecke, A. et al. Protective role of CXC receptor 4/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis. Circ. Res. 102, 209–217 (2008). This study provides evidence for the recruitment and contribution of neutrophils to atherosclerotic plaques, which is controlled by a protective function of the CXCL12–CXCR4 axis.
  Article CAS PubMed Google Scholar
• van Leeuwen, M. et al. Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR−/− mice. Arterioscler. Thromb. Vasc. Biol. 28, 84–89 (2008).
  Article CAS PubMed Google Scholar
• Bot, I. et al. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apolipoprotein E-deficient mice. Circulation 115, 2516–2525 (2007).
  Article CAS PubMed Google Scholar
• Sun, J. et al. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nature Med. 13, 719–724 (2007). References 4 and 5 provide important mechanistic insights on the role of mast cells and their secretory products in promoting atherogenesis and plaque instability.
  Article CAS PubMed Google Scholar
• Kostis, J. B., Turkevich, D. & Sharp, J. Association between leukocyte count and the presence and extent of coronary atherosclerosis as determined by coronary arteriography. Am. J. Cardiol. 53, 997–999 (1984).
  Article CAS PubMed Google Scholar
• Avanzas, P. et al. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175, 151–157 (2004).
  Article CAS PubMed Google Scholar
• Kawaguchi, H. et al. Band neutrophil count and the presence and severity of coronary atherosclerosis. Am. Heart J. 132, 9–12 (1996).
  Article CAS PubMed Google Scholar
• Naruko, T. et al. Neutrophil infiltration of culprit lesions in acute coronary syndromes. Circulation 106, 2894–2900 (2002).
  Article PubMed Google Scholar
• Larionov, S., Dedeck, O., Birkenmeier, G. & Thal, D. R. Expression of α2-macroglobulin, neutrophil elastase, and interleukin-1α differs in early-stage and late-stage atherosclerotic lesions in the arteries of the circle of Willis. Acta Neuropathol. 113, 33–43 (2007).
  Article CAS PubMed Google Scholar
• Eliason, J. L. et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 112, 232–240 (2005).
  Article CAS PubMed Google Scholar
• Zhang, R. et al. Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286, 2136–2142 (2001).
  Article CAS PubMed Google Scholar
• Chevrier, I., Tregouet, D. A., Massonnet-Castel, S., Beaune, P. & Loriot, M. A. Myeloperoxidase genetic polymorphisms modulate human neutrophil enzyme activity: genetic determinants for atherosclerosis? Atherosclerosis 188, 150–154 (2006).
  Article CAS PubMed Google Scholar
• Hemdahl, A. L. et al. Expression of neutrophil gelatinase-associated lipocalin in atherosclerosis and myocardial infarction. Arterioscler. Thromb. Vasc. Biol. 26, 136–142 (2006).
  Article CAS PubMed Google Scholar
• Galis, Z. S. & Khatri, J. J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly. Circ. Res. 90, 251–262 (2002).
  Article CAS PubMed Google Scholar
• Soehnlein, O. et al. Neutrophil secretion products pave the way for inflammatory monocytes. Blood 112, 1461–1471 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Tabas, I. Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25, 2255–2264 (2005).
  Article CAS PubMed Google Scholar
• Ait-Oufella, H. et al. Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice. Circulation 115, 2168–2177 (2007). This paper shows that the impaired capacity of macrophages for the clearance of apoptotic debris is due to genetic deletion of a crucial component that accelerates atherosclerosis.
  Article CAS PubMed Google Scholar
• Sugiyama, S. et al. Hypochlorous acid, a macrophage product, induces endothelial apoptosis and tissue factor expression: involvement of myeloperoxidase-mediated oxidant in plaque erosion and thrombogenesis. Arterioscler. Thromb. Vasc. Biol. 24, 1309–1314 (2004).
  Article CAS PubMed Google Scholar
• Kovanen, P. T., Kaartinen, M. & Paavonen, T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92, 1084–1088 (1995).
  Article CAS PubMed Google Scholar
• Kovanen, P. T. Mast cells: multipotent local effector cells in atherothrombosis. Immunol. Rev. 217, 105–122 (2007).
  Article CAS PubMed Google Scholar
• Hallgren, J. & Gurish, M. F. Pathways of murine mast cell development and trafficking: tracking the roots and routes of the mast cell. Immunol. Rev. 217, 8–18 (2007).
  Article CAS PubMed Google Scholar
• Constantinides, P. Mast cells and susceptibility to experimental atherosclerosis. Science 117, 505–506 (1953).
  Article CAS PubMed Google Scholar
• Lee-Rueckert, M. & Kovanen, P. T. Mast cell proteases: physiological tools to study functional significance of high density lipoproteins in the initiation of reverse cholesterol transport. Atherosclerosis 189, 8–18 (2006).
  Article CAS PubMed Google Scholar
• Jeziorska, M., McCollum, C. & Woolley, D. E. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. J. Pathol. 182, 115–122 (1997).
  Article CAS PubMed Google Scholar
• Johnson, J. L., Jackson, C. L., Angelini, G. D. & George, S. J. Activation of matrix-degrading metalloproteinases by mast cell proteases in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 18, 1707–1715 (1998).
  Article CAS PubMed Google Scholar
• Caughey, G. H. Mast cell tryptases and chymases in inflammation and host defense. Immunol. Rev. 217, 141–154 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Sun, J. et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J. Clin. Invest. 117, 3359–3368 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Haley, K. J. et al. Overexpression of eotaxin and the CCR3 receptor in human atherosclerosis: using genomic technology to identify a potential novel pathway of vascular inflammation. Circulation 102, 2185–2189 (2000).
  Article CAS PubMed Google Scholar
• Bischoff, S. C., Krieger, M., Brunner, T. & Dahinden, C. A. Monocyte chemotactic protein 1 is a potent activator of human basophils. J. Exp. Med. 175, 1271–1275 (1992).
  Article CAS PubMed Google Scholar
• Watanabe, T. et al. Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab. Invest. 53, 80–90 (1985).
  CAS PubMed Google Scholar
• Gown, A. M., Tsukada, T. & Ross, R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 125, 191–207 (1986).
  CAS PubMed PubMed Central Google Scholar
• Braunersreuther, V. et al. Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice. Arterioscler. Thromb. Vasc. Biol. 27, 373–379 (2007).
  Article CAS PubMed Google Scholar
• Zernecke, A., Shagdarsuren, E. & Weber C. Chemokines in atherosclerosis: an update. Arterioscler. Thromb. Vasc. Biol. 19 June 2008 (doi:10.1161/ATVBAHA.107.161174).
  Article CAS PubMed Google Scholar
• Ylitalo, R., Oksala, O., Yla-Herttuala, S. & Ylitalo, P. Effects of clodronate (dichloromethylene bisphosphonate) on the development of experimental atherosclerosis in rabbits. J. Lab. Clin. Med. 123, 769–776 (1994).
  CAS PubMed Google Scholar
• Stoneman, V. et al. Monocyte/macrophage suppression in CD11b diphtheria toxin receptor transgenic mice differentially affects atherogenesis and established plaques. Circ. Res. 100, 884–893 (2007). This paper shows the differential effects of stage-specific depletion of monocytes and macrophages, which inhibited early atherogenesis and non-established plaques.
  Article CAS PubMed PubMed Central Google Scholar
• Swirski, F. K. et al. Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease. Proc. Natl Acad. Sci. USA 103, 10340–10345 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Swirski, F. K. et al. Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117, 195–205 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Tacke, F. et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117, 185–194 (2007). This paper shows that monocyte subsets use different chemokine receptors for their recruitment to atherosclerotic plaques, which suggests that there are options for selective or combined antagonism.
  Article CAS PubMed PubMed Central Google Scholar
• Geissmann, F., Jung, S. & Littman, D. R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19, 71–82 (2003).
  Article CAS PubMed Google Scholar
• Weber, C. et al. Differential chemokine receptor expression and function in human monocyte subpopulations. J. Leukoc. Biol. 67, 699–704 (2000).
  Article CAS PubMed Google Scholar
• Auffray, C. et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 317, 666–670 (2007).
  Article CAS PubMed Google Scholar
• Qiao, J. H. et al. Role of macrophage colony-stimulating factor in atherosclerosis: studies of osteopetrotic mice. Am. J. Pathol. 150, 1687–1699 (1997).
  CAS PubMed PubMed Central Google Scholar
• Saederup, N., Chan, L., Lira, S. A. & Charo, I. F. Fractalkine deficiency markedly reduces macrophage accumulation and atherosclerotic lesion formation in CCR2−/− mice: evidence for independent chemokine functions in atherogenesis. Circulation 117, 1642–1648 (2008).
  Article CAS PubMed Google Scholar
• Combadiere, C. et al. Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice. Circulation 117, 1649–1657 (2008).
  Article CAS PubMed Google Scholar
• Dansky, H. M., Charlton, S. A., Harper, M. M. & Smith, J. D. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl Acad. Sci. USA 94, 4642–4646 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Zhou, X., Nicoletti, A., Elhage, R. & Hansson, G. K. Transfer of CD4+ T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 102, 2919–2922 (2000).
  Article CAS PubMed Google Scholar
• Hansson, G. K. & Libby, P. The immune response in atherosclerosis: a double-edged sword. Nature Rev. Immunol. 6, 508–519 (2006).
  Article CAS Google Scholar
• Zhou, X., Paulsson, G., Stemme, S. & Hansson, G. K. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apoE-knockout mice. J. Clin. Invest. 101, 1717–1725 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Tellides, G. et al. Interferon-γ elicits arteriosclerosis in the absence of leukocytes. Nature 403, 207–211 (2000).
  Article CAS PubMed Google Scholar
• Buono, C. et al. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc. Natl Acad. Sci. USA 102, 1596–1601 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mallat, Z. et al. Protective role of interleukin-10 in atherosclerosis. Circ. Res. 85, e17–e24 (1999).
  Article CAS PubMed Google Scholar
• Furukawa, Y. et al. Interleukin-10 (IL-10) augments allograft arterial disease: paradoxical effects of IL-10 in vivo. Am. J. Pathol. 155, 1929–1939 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Rahmani, M., Cruz, R. P., Granville, D. J. & McManus, B. M. Allograft vasculopathy versus atherosclerosis. Circ. Res. 99, 801–815 (2006).
  Article CAS PubMed Google Scholar
• Schulte, S., Sukhova, G. K. & Libby, P. Genetically programmed biases in Th1 and Th2 immune responses modulate atherogenesis. Am. J. Pathol. 172, 1500–1508 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Henderson, E. L. et al. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation 99, 96–104 (1999).
  Article CAS PubMed Google Scholar
• Taleb, S., Tedgui, A. & Mallat, Z. Regulatory T-cell immunity and its relevance to atherosclerosis. J. Intern. Med. 263, 489–499 (2008). This is a comprehensive review of the current knowledge of the regulatory T-cell response and the major cytokines that are involved in its modulation in the context of atherosclerosis.
  Article CAS PubMed Google Scholar
• Vanderlaan, P. A. & Reardon, C. A. Thematic review series: the immune system and atherogenesis. The unusual suspects: an overview of the minor leukocyte populations in atherosclerosis. J. Lipid Res. 46, 829–838 (2005).
  Article CAS PubMed Google Scholar
• Koch, A. E. et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am. J. Pathol. 137, 1199–1213 (1990).
  CAS PubMed PubMed Central Google Scholar
• Ramshaw, A. L. & Parums, D. V. Immunohistochemical characterization of inflammatory cells associated with advanced atherosclerosis. Histopathology 17, 543–552 (1990).
  Article CAS PubMed Google Scholar
• Walton, L. J., Powell, J. T. & Parums, D. V. Unrestricted usage of immunoglobulin heavy chain genes in B cells infiltrating the wall of atherosclerotic abdominal aortic aneurysms. Atherosclerosis 135, 65–71 (1997).
  Article CAS PubMed Google Scholar
• Watanabe, M. et al. Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery. J. Atheroscler Thromb. 14, 325–331 (2007).
  Article PubMed Google Scholar
• Zhou, X. & Hansson, G. K. Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice. Scand. J. Immunol. 50, 25–30 (1999).
  Article CAS PubMed Google Scholar
• Moos, M. P. et al. The lamina adventitia is the major site of immune cell accumulation in standard chow-fed apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 25, 2386–2391 (2005).
  Article CAS PubMed Google Scholar
• Galkina, E. et al. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 203, 1273–1282 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Caligiuri, G., Nicoletti, A., Poirier, B. & Hansson, G. K. Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice. J. Clin. Invest. 109, 745–753 (2002). This study shows that spleen-associated immune protection against atherosclerosis in mice is conferred by B cells and is concomitant with increased antibody titres to oxLDL.
  Article CAS PubMed PubMed Central Google Scholar
• Shortman, K. & Naik, S. H. Steady-state and inflammatory dendritic-cell development. Nature Rev. Immunol. 7, 19–30 (2007).
  Article CAS Google Scholar
• Millonig, G. et al. Network of vascular-associated dendritic cells in intima of healthy young individuals. Arterioscler. Thromb. Vasc. Biol. 21, 503–508 (2001).
  Article CAS PubMed Google Scholar
• Jongstra-Bilen, J. et al. Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203, 2073–2083 (2006).
  Article CAS PubMed PubMed Central Google Scholar
• Liu, P. et al. CX3CR1 deficiency impairs dendritic cell accumulation in arterial intima and reduces atherosclerotic burden. Arterioscler. Thromb. Vasc. Biol. 28, 243–250 (2008).
  Article CAS PubMed Google Scholar
• Bobryshev, Y. V. Dendritic cells in atherosclerosis: current status of the problem and clinical relevance. Eur. Heart J. 26, 1700–1704 (2005).
  Article PubMed Google Scholar
• Yilmaz, A. et al. Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques. Atherosclerosis 176, 101–110 (2004).
  Article CAS PubMed Google Scholar
• Yilmaz, A. et al. Decrease in circulating myeloid dendritic cell precursors in coronary artery disease. J. Am. Coll. Cardiol. 48, 70–80 (2006).
  Article CAS PubMed Google Scholar
• Shaposhnik, Z., Wang, X., Weinstein, M., Bennett, B. J. & Lusis, A. J. Granulocyte macrophage colony-stimulating factor regulates dendritic cell content of atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 27, 621–627 (2007).
  Article CAS PubMed Google Scholar
• Han, J. W. et al. Vessel wall-embedded dendritic cells induce T-cell autoreactivity and initiate vascular inflammation. Circ. Res. 102, 546–553 (2008).
  Article CAS PubMed Google Scholar
• Alderman, C. J. et al. Effects of oxidised low density lipoprotein on dendritic cells: a possible immunoregulatory component of the atherogenic micro-environment? Cardiovasc. Res. 55, 806–819 (2002).
  Article CAS PubMed Google Scholar
• Angeli, V. et al. Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21, 561–574 (2004).
  Article CAS PubMed Google Scholar
• Shamshiev, A. T. et al. Dyslipidemia inhibits Toll-like receptor-induced activation of CD8α-negative dendritic cells and protective Th1 type immunity. J. Exp. Med. 204, 441–452 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Niessner, A. et al. Synergistic proinflammatory effects of the antiviral cytokine interferon-α and Toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 116, 2043–2052 (2007). This study shows that IFNα that is secreted by pDCs in atherosclerotic plaques stimulates IFNγ production by CD4+ T cells and sensitizes myeloid DCs to pathogen-derived TLR4 ligands to promote plaque destabilization.
  Article CAS PubMed Google Scholar
• Colonna, M., Trinchieri, G. & Liu, Y. J. Plasmacytoid dendritic cells in immunity. Nature Immunol. 5, 1219–1226 (2004).
  Article CAS Google Scholar
• Niessner, A. et al. Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-α. Circulation 114, 2482–2489 (2006).
  Article CAS PubMed Google Scholar
• Ochando, J. C. et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nature Immunol. 7, 652–662 (2006).
  Article CAS Google Scholar
• Asahara, T. et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275, 964–967 (1997).
  Article CAS PubMed Google Scholar
• Simper, D., Stalboerger, P. G., Panetta, C. J., Wang, S. & Caplice, N. M. Smooth muscle progenitor cells in human blood. Circulation 106, 1199–1204 (2002).
  Article CAS PubMed Google Scholar
• Urbich, C. & Dimmeler, S. Endothelial progenitor cells: characterization and role in vascular biology. Circ. Res. 95, 343–353 (2004).
  Article CAS PubMed Google Scholar
• Hristov, M. & Weber, C. Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance. J. Cell. Mol. Med. 8, 498–508 (2004).
  Article PubMed PubMed Central Google Scholar
• Zengin, E. et al. Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133, 1543–1551 (2006).
  Article CAS PubMed Google Scholar
• Peichev, M. et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 95, 952–958 (2000).
  CAS PubMed Google Scholar
• Romagnani, P. et al. CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ. Res. 97, 314–322 (2005).
  Article CAS PubMed Google Scholar
• Hristov, M. et al. Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ. Res. 100, 590–597 (2007).
  Article CAS PubMed Google Scholar
• De Palma, M., Murdoch, C., Venneri, M. A., Naldini, L. & Lewis, C. E. Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implications. Trends Immunol. 28, 519–524 (2007).
  Article CAS PubMed Google Scholar
• Yoder, M. C. et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109, 1801–1809 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Case, J. et al. Human CD34+AC133+VEGFR-2+ cells are not endothelial progenitor cells but distinct, primitive hematopoietic progenitors. Exp. Hematol. 35, 1109–1118 (2007).
  Article CAS PubMed Google Scholar
• Timmermans, F. et al. Endothelial outgrowth cells are not derived from CD133+ cells or CD45+ hematopoietic precursors. Arterioscler. Thromb. Vasc. Biol. 27, 1572–1579 (2007).
  Article CAS PubMed Google Scholar
• Sugiyama, S. et al. Characterization of smooth muscle-like cells in circulating human peripheral blood. Atherosclerosis 187, 351–362 (2006).
  Article CAS PubMed Google Scholar
• Zernecke, A. et al. SDF-1α/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ. Res. 96, 784–791 (2005).
  Article CAS PubMed Google Scholar
• Sakihama, H. et al. Stromal cell-derived factor-1 and CXCR4 interaction is critical for development of transplant arteriosclerosis. Circulation 110, 2924–2930 (2004).
  Article CAS PubMed Google Scholar
• Bernhagen, J. et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nature Med. 13, 587–596 (2007). This study describes how targeting the cytokine MIF as a dual chemokine-receptor agonist can inhibit both monocyte and T-cell recruitment, which then leads to plaque regression.
  Article CAS PubMed Google Scholar
• Haghighat, A., Weiss, D., Whalin, M. K., Cowan, D. P. & Taylor, W. R. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation 115, 2049–2054 (2007).
  Article CAS PubMed Google Scholar
• Werner, N. & Nickenig, G. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler. Thromb. Vasc. Biol. 26, 257–266 (2006).
  Article CAS PubMed Google Scholar
• George, J. et al. Transfer of endothelial progenitor and bone marrow cells influences atherosclerotic plaque size and composition in apolipoprotein E knockout mice. Arterioscler. Thromb. Vasc. Biol. 25, 2636–2641 (2005). This study indicates that EPCs may promote atherosclerosis in mice, thereby introducing an important caveat to their clinical administration.
  Article CAS PubMed Google Scholar
• Foteinos, G., Hu, Y., Xiao, Q., Metzler, B. & Xu, Q. Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice. Circulation 117, 1856–1863 (2008).
  Article PubMed Google Scholar
• Purhonen, S. et al. Bone marrow-derived circulating endothelial precursors do not contribute to vascular endothelium and are not needed for tumor growth. Proc. Natl Acad. Sci. USA 105, 6620–6625 (2008).
  Article CAS PubMed PubMed Central Google Scholar
• Sata, M. et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nature Med. 8, 403–409 (2002).
  Article CAS PubMed Google Scholar
• Hillebrands, J. L., Klatter, F. A. & Rozing, J. Origin of vascular smooth muscle cells and the role of circulating stem cells in transplant arteriosclerosis. Arterioscler. Thromb. Vasc Biol. 23, 380–387 (2003).
  Article CAS PubMed Google Scholar
• Caplice, N. M. et al. Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation. Proc. Natl Acad. Sci. USA 100, 4754–4759 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bentzon, J. F., Sondergaard, C. S., Kassem, M. & Falk, E. Smooth muscle cells healing atherosclerotic plaque disruptions are of local, not blood, origin in apolipoprotein E knockout mice. Circulation 116, 2053–2061 (2007).
  Article CAS PubMed Google Scholar
• Zoll, J. et al. Role of human smooth muscle cell progenitors in atherosclerotic plaque development and composition. Cardiovasc. Res. 77, 471–480 (2008). This study shows that infusion of SPCs in mice can limit atherosclerotic plaque development and promote plaque stability.
  Article CAS PubMed Google Scholar
• Uccelli, A., Pistoia, V. & Moretta, L. Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol. 28, 219–226 (2007).
  Article CAS PubMed Google Scholar
• Xu, Q. The role of stem cells in vein graft remodelling. Biochem. Soc. Trans. 35, 895–899 (2007).
  Article CAS PubMed Google Scholar
• Martinez, F. O., Gordon, S., Locati, M. & Mantovani, A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J. Immunol. 177, 7303–7311 (2006).
  Article CAS PubMed Google Scholar
• Llodra, J. et al. Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques. Proc. Natl Acad. Sci. USA 101, 11779–11784 (2004). This study proposes that conversion of lesional monocyte-derived cells into migratory CD11c+ DC-like cells favours their egress from plaques to mediate regression.
  Article CAS PubMed PubMed Central Google Scholar
• Sozzani, S., Rusnati, M., Riboldi, E., Mitola, S. & Presta, M. Dendritic cell-endothelial cell cross-talk in angiogenesis. Trends Immunol. 28, 385–392 (2007).
  Article CAS PubMed Google Scholar
• Menges, M. et al. Repetitive injections of dendritic cells matured with tumor necrosis factor α induce antigen-specific protection of mice from autoimmunity. J. Exp. Med. 195, 15–21 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Nilsson, J., Hansson, G. K. & Shah, P. K. Immunomodulation of atherosclerosis: implications for vaccine development. Arterioscler. Thromb. Vasc. Biol. 25, 18–28 (2005).
  Article CAS PubMed Google Scholar
• Lumeng, C. N., Bodzin, J. L. & Saltiel, A. R. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J. Clin. Invest. 117, 175–184 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Nahrendorf, M. et al. The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J. Exp. Med. 204, 3037–3047 (2007).
  Article CAS PubMed PubMed Central Google Scholar
• Guven, H., Shepherd, R. M., Bach, R. G., Capoccia, B. J. & Link, D. C. The number of endothelial progenitor cell colonies in the blood is increased in patients with angiographically significant coronary artery disease. J. Am. Coll. Cardiol. 48, 1579–1587 (2006).
  Article PubMed Google Scholar
• Xiao, Q. et al. Endothelial progenitor cells, cardiovascular risk factors, cytokine levels and atherosclerosis — results from a large population-based study. PLoS ONE 2, e975 (2007).
  Article PubMed PubMed Central CAS Google Scholar
• Hristov, M. et al. Reduced numbers of circulating endothelial progenitor cells in patients with coronary artery disease associated with long-term statin treatment. Atherosclerosis 192, 413–420 (2007).
  Article CAS PubMed Google Scholar